Enhancing T cell therapy through TCR-signaling-responsive nanoparticle drug delivery-Reference-Cited by-同舟云学术

Enhancing T cell therapy through TCR-signaling-responsive nanoparticle drug delivery

Published:2018-07-09 Issue:8 Volume:36 Page:707-716
ISSN:1087-0156
Container-title:Nature Biotechnology
language:en
Short-container-title:Nat Biotechnol

Author:

Tang Li^ORCID,Zheng Yiran,Melo Mariane Bandeira,Mabardi Llian,Castaño Ana P,Xie Yu-Qing,Li Na,Kudchodkar Sagar B^ORCID,Wong Hing C,Jeng Emily K,Maus Marcela V^ORCID,Irvine Darrell J

Publisher

Springer Science and Business Media LLC

Subject

Biomedical Engineering,Molecular Medicine,Applied Microbiology and Biotechnology,Bioengineering,Biotechnology

Link

http://www.nature.com/articles/nbt.4181.pdf

Reference50 articles.

1. Rosenberg, S.A. & Restifo, N.P. Adoptive cell transfer as personalized immunotherapy for human cancer. Science 348, 62–68 (2015).

2. Gill, S. & June, C.H. Going viral: chimeric antigen receptor T cell therapy for hematological malignancies. Immunol. Rev. 263, 68–89 (2015).

3. Corrigan-Curay, J. et al. T cell immunotherapy: looking forward. Mol. Ther. 22, 1564–1574 (2014).

4. Johnson, L.A. et al. Rational development and characterization of humanized anti–EGFR variant III chimeric antigen receptor T cells for glioblastoma. Sci. Transl. Med. 7, 275ra22 (2015).

5. Klebanoff, C.A. et al. IL-15 enhances the in vivo antitumor activity of tumor-reactive CD8+ T cells. Proc. Natl. Acad. Sci. USA 101, 1969–1974 (2004).

Cited by 501 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Advancements of engineered live oncolytic biotherapeutics (microbe/virus/cells): Preclinical research and clinical progress;Journal of Controlled Release;2024-11

2. Jump-starting chimeric antigen receptor-T cells to go the extra mile with nanotechnology;Current Opinion in Biotechnology;2024-10

3. Stimuli‐Responsive Nanocarriers as Active Enhancers of Antitumoral Immunotherapy;Advanced Materials Interfaces;2024-09-10

4. Design of nanosystems for melanoma treatment;International Journal of Pharmaceutics;2024-09

5. Intratumoral injection and retention hold promise to improve cytokine therapies for cancer;Frontiers in Oncology;2024-08-26